Whilst these medications are not primarily indicated for cholesterol reduction, emerging evidence demonstrates modest but clinically relevant improvements in lipid profiles
References WeGovy Label: accessdata.fda.gov/ JAMA Network Open Study: jamanetwork.com National Library of Medicine: pmc.ncbi.nlm.nih.gov Journal of Clinical Endocrinology & Metabolism : academic.oup.com University of Colorado Anschutz Medical Campus Study: medschool.cuanschutz.edu Health.com Study: health.com FDA Documentation: fda.gov JBMR Plus: academic.oup.com/jbmrplus Harvard University: health.harvard.edu
Retatrutide-related nausea, vomiting, diarrhea, or reduced food and fluid intake can also increase the risk of dehydration
A 2,700person realworld study presented at the 2025 European Congress on Obesity showed an average 16% weightloss over 64 weeks at microdose levels of semaglutide
While they sit on opposite sides of this debate, they dont completely disagree and have many moments of overlap and agreement that enrich both perspectives
Following the guidelines for studies involving participants with a type 2 diabetes diagnosis, there was no adjunct nutrition or physical activity plans provided to the subjects